Online citations, reference lists, and bibliographies.
← Back to Search

Epidemiology Of Malignant Mesothelioma In Australia.

A. Musk, N. de Klerk
Published 2004 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
In Australia, consumption of asbestos peaked in about 1975 at around 70,000t per year--the majority being used for asbestos cement manufacture. Chrysotile, amphibole and crocidolite have all been mined in Australia and employment records from the single company which mined most of the crocidolite deposits at Wittenoom have formed the basis of an ongoing cohort mortality study of the workforce.
This paper references



This paper is referenced by
Peritoneal mesothelioma: current understanding and management
T. Chua (2009)
10.1016/J.CCM.2006.01.004
Management of malignant pleural mesothelioma.
S. West (2006)
10.1136/oem.2007.038315
Predicted mortality from malignant mesothelioma among women exposed to blue asbestos at Wittenoom, Western Australia
A. Reid (2008)
10.1136/thoraxjnl-2013-204161
Mesothelioma risk after 40 years since first exposure to asbestos: a pooled analysis
A. Reid (2014)
10.1016/J.LUNGCAN.2006.01.007
Recombinant GM-CSF plus autologous tumor cells as a vaccine for patients with mesothelioma.
A. Powell (2006)
10.1016/j.ejca.2010.08.015
MexTAg mice exposed to asbestos develop cancer that faithfully replicates key features of the pathogenesis of human mesothelioma.
C. Robinson (2011)
Optimising the use of indwelling pleural catheter in the management of malignant pleural effusion
Rajesh Thomas (2017)
Malignant pleural mesothelioma : novel biomarkers and related pathways
Filip Mundt (2013)
10.1111/j.1440-1843.2005.00694.x
Pathogenesis of malignant pleural mesothelioma
M. Jaurand (2005)
10.1183/09059180.00007014
Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic
O. D. Røe (2015)
10.3892/or.2015.3771
Wnt7A is a putative prognostic and chemosensitivity marker in human malignant pleural mesothelioma
T. Hirata (2015)
10.1016/J.HOC.2005.09.007
Detection of malignant mesothelioma in asbestos-exposed individuals: the potential role of soluble mesothelin-related protein.
J. Creaney (2005)
10.1111/1754-9485.12291
Hemithoracic radiation therapy after extrapleural pneumonectomy for malignant pleural mesothelioma: Toxicity and outcomes at an Australian institution
A. Bece (2015)
Sistemazione and death: the role of the Wittenoom asbestos mine in the lives and deaths of Italian transnational workers
A. D. Pasquale (2013)
10.1093/annhyg/mev017
Development of a Job-Exposure Matrix (AsbJEM) to Estimate Occupational Exposure to Asbestos in Australia.
Svein C van Oyen (2015)
10.1002/ijc.23331
Cancer incidence among women and girls environmentally and occupationally exposed to blue asbestos at Wittenoom, Western Australia
A. Reid (2008)
10.1080/07347332.2014.917142
Dusted Community: Piloting a Virtual Peer-to-Peer Support Community for People with an Asbestos-Related Diagnosis and Their Families
D. Kozlowski (2014)
Body composition analysis in the assessment of cancer cachexia treatment outcomes.
A. Aslani (2008)
10.1016/j.lungcan.2011.01.011
Mesothelin and kidney function--analysis of relationship and implications for mesothelioma screening.
N. Boudville (2011)
10.4161/epi.6.8.16074
The relationship between tumor MSLN methylation and serum mesothelin (SMRP) in mesothelioma
H. Nelson (2011)
10.1080/13557858.2017.1280138
Variations in mesothelioma mortality rates among migrants to Australia and Australian-born
S. Si (2018)
10.1016/S0140-6736(04)17108-0
Pleural mesothelioma: little evidence, still time to do trials
T. Treasure (2004)
10.1111/j.1743-7563.2010.01316.x
Audit of patients with mesothelioma treated with pemetrexed in a single institution in Western Australia
A. Hasani (2010)
10.1016/j.bbcan.2015.08.002
Lung cancer: Biology and treatment options.
H. Lemjabbar-Alaoui (2015)
10.1371/journal.pone.0066685
Mutational Analysis of Hedgehog Signaling Pathway Genes in Human Malignant Mesothelioma
C. Lim (2013)
SYNDECAN-1 INSIGHTS IN MESOTHELIOMA THESIS FOR DOCTORAL DEGREE ( Ph . D . ) By Ghazal
Heidari Hamedani (2017)
10.1007/s12253-009-9210-9
Impact of Tumor Angiogenesis in Peritoneal Mesothelioma After Radical Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy
T. Chua (2009)
10.1097/MCP.0b013e32832b98eb
Serum and pleural fluid biomarkers for mesothelioma
J. Creaney (2009)
10.1517/14712598.5.8.1039
Gene therapy of mesothelioma
D. Nelson (2005)
10.1155/2014/413946
Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma
J. Creaney (2014)
10.1111/j.1445-5994.2010.02223.x
Malignant mesothelioma
S. Kao (2010)
10.1183/09031936.00148211
A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions
C. Hooper (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar